Skip to main content
Scott Solomon, MD, Cardiology, Boston, MA, Brigham and Women's Hospital

ScottDavidSolomonMD

Cardiology Boston, MA

Professor, Medicine-Brigham & Women's Hospital, Harvard Medical School

Dr. Solomon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Solomon's full profile

Already have an account?

  • Office

    75 Francis St Pbb1
    Brigham And Womens Hospital Cardiovascular Division
    Boston, MA 02115
    Phone+1 617-732-7182
  • Is this information wrong?

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1989 - 1992
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1986 - 1989
  • Harvard Medical School
    Harvard Medical SchoolClass of 1986

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1988 - 2025
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Mini Focus on Diabetes Original Investigation Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk  
    Nora Franceschini, Amil Shah, Calum A MacRae, Sara B Seidelmann, Scott D Solomon, Susan Cheng, ScienceDirect
  • Growth Differentiation Factor‐15 Is Not Modified by sacubitril/valsartan and Is an Independent Marker of Risk in Patients with Heart Failure and Reduced Ejection Fract...  
    Milton Packer, Scott D Solomon, Michael R Zile, European Journal of Heart Failure
  • Clinical Research Vaccination Trends in Patients with Heart Failure: Insights from Get with the Guidelines–Heart Failure  
    Adam D DeVore, Adrian F Hernandez, Scott D Solomon, Orly Vardeny, Ankeet S Bhatt, Gregg C Fonarow, Robert J Mentz, Clyde W Yancy, Ileana L Pina, ScienceDirect
  • Join now to see all

Lectures

  • Heart Failure with Preserved Ejection Fraction: From Mechanisms to Therapies 
    Scientific Sessions 2007, Orlando, Florida, USA
  • Heart Failure with Preserved Ejection Fraction: From Mechanisms to Therapies 
    European Society of Cardiology, ESC Congress 2012, Munich, Germany
  • Heart Failure with Preserved Ejection Fraction: From Mechanisms to Therapies 
    European League Against Rheumatism, Annual European Congress of Rheumatology 2008, Paris, France
  • Join now to see all

Press Mentions

  • New Data, Updated Guidance ‘Dramatically’ Changing HF Treatment Landscape
    New Data, Updated Guidance ‘Dramatically’ Changing HF Treatment LandscapeDecember 16th, 2022
  • DELIVER Trial: For HF Patients, Dapagliflozin Beneficial Regardless of Ejection Fraction
    DELIVER Trial: For HF Patients, Dapagliflozin Beneficial Regardless of Ejection FractionAugust 29th, 2022
  • Dapagliflozin HFpEF Benefit Recasts HF Treatment: DELIVER -News Forest
    Dapagliflozin HFpEF Benefit Recasts HF Treatment: DELIVER -News ForestAugust 28th, 2022
  • Join now to see all

Professional Memberships

Hospital Affiliations